Sort
326,823 grants matching “clinical trial”
DATA ANALYSIS AND STATISTICAL PROGRAMING SUPPORT (BASE CONTRACT) COMPANY: PROSPECTIVE GROUP
$2,279,479Paul Converti · · N02 · FY2019 · HD
Section on Skeletal Disorders and Mineral Homeostasis
$2,279,342Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE
Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases
$2,279,288Jiang He · Tulane University Of Louisiana · P20 · FY2023 · GM
Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder
$2,279,021David G Amaral · University Of California At Davis · P50 · FY2019 · HD
DAIT CLINICAL SITE MONITORING CENTER
$2,279,000Mary Glessner · Ppd Development Lp · N01 · FY2015 · AI
Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder
$2,278,831David G Amaral · University Of California At Davis · P50 · FY2020 · HD
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,278,760David S Stephens · Emory University · UL1 · FY2010 · RR
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
$2,278,757Daniel William Cramer · Brigham And Women'S Hospital · P50 · FY2007 · CA
Brain Imaging, APOE & the Preclinical Course of Alzheimer's Disease
$2,278,734Eric M Reiman · Banner Alzheimer'S Institute · R01 · FY2017 · AG
PROTON RADIATION THERAPY RESEARCH
$2,278,576Massachusetts General Hospital · P01 · FY2005 · CA
Clinical Trials of Biodefense Vaccines (Dengue)
$2,278,429Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
NEUTRALIZING ANTIBODY & AAV FIX GENE THERAPY
$2,278,426Richard J Samulski · Univ Of North Carolina Chapel Hill · P01 · FY2017 · HL
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,278,344Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
$2,278,318Matthew D Ringel · Ohio State University · P50 · FY2017 · CA
SPORE in Gl Cancer
$2,278,307Robert J Coffey · Vanderbilt University · P50 · FY2007 · CA
SPORE in Gl Cancer
$2,278,307Robert J Coffey · Vanderbilt University · P50 · FY2009 · CA
SPORE in Gl Cancer
$2,278,307Robert J Coffey · Vanderbilt University · P50 · FY2008 · CA
SPORE in Gl Cancer
$2,278,307Robert J Coffey · Vanderbilt University · P50 · FY2010 · CA
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,278,235Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Neutralizing Antibody & AAV FIX Gene Therapy
$2,278,230Richard J Samulski · Univ Of North Carolina Chapel Hill · P01 · FY2014 · HL
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer
$2,278,098Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2019 · CA
Sen-Survivors: An open-label intervention trial for frailty and senescence
$2,277,711Gregory Armstrong · St. Jude Children'S Research Hospital · U01 · FY2020 · CA
SPORE in Prostate Cancer
$2,277,704Donald J. Tindall · Mayo Clinic Rochester · P50 · FY2007 · CA
Sexually Transmitted Infections Clinical Trials Group: Phase II Clinical Trial for Bacterial Vaginosis
$2,277,679Edward Hook · University Of Alabama At Birmingham · N01 · FY2018 · AI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,277,638Harry Bernard Greenberg · Stanford University · UL1 · FY2008 · RR